Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASPER study
PACTR202108825067735Phase 4Completed
- Sponsor
- PEARLS (Preeclampsia Research Laboratories)
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in preeclampsia and eclampsia (2 arms), sponsored by PEARLS (Preeclampsia Research Laboratories). Primary endpoint: preeclampsia and/or eclampsia. Started Sep 2021; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaeclampsia
Beyond the preview
Go deeper on PACTR202108825067735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108825067735.